Course 2: Pharmacovigilance and Risk Management Planning
Stella C.F. Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP
- Vice President, Global Head of Early Access & Risk Management,
- IQVIA, United Kingdom
Dr Stella Blackburn is currently VP, Global Head of Early Access & Risk Management at IQVIA. She joined IQVIA in April 2014 after more than 25 years working in PhV and pharmacoepi in industry and the European Medicines Agency. Stella is a Fellow of the International Society of Pharmacoepidemiology (ISPE), the Royal College of Physicians of Edinburgh and the Faculty of Pharmaceutical Medicine. She is a past President of ISPE, an honorary lecturer at LSHTM and Visiting Scientist at MIT.
William Gregory, PhD
- Safety and Risk Management
- Pfizer Inc, United States
He received formal training in infectious diseases and molecular mechanisms of pathogenesis and has more than 15 years of experience directing global product development and registration programs. He also has extensive experience in pharmacovigilance and health informatics as well as the evaluation and exchange of safety data. He has served with other experts and senior scientists on many consensus panels, including ICH, CIOMS, ISO, and HL7.